Interestingly, the GBM cell lines expressing higher levels of ARPC1B were strikingly more sensitive to AZD6738 (synonyms: ceralasertib) (Fig. 7A, Fig. S9A and Table S3), which is a selective inhibitor of ATR [54]. This evidence concerns the gene ARPC1B and glioblastoma.